Article and Video CATEGORIES
Dr. Jack West asks the question of whether newer, more active ALK inhibitors such as alectinib should be used as first line therapy rather than for acquired resistance, including introducing the ALEX trial that is trying to answer this question.
November is Lung Cancer Awareness Month. What are you grateful for?
Watch, read, and then share your own stories of empowerment in our online forum. Your story may inspire others.
[powerpress]
Get more information about the ALEX Trial.
[ratingwidget post_id=0]
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi sbunit and welcome to Grace. I'm sorry about your mom and you need to be here looking for answers. Unfortunately there just aren't good answers to these questions. But yes...
As a follow up to my original question, the specific mutations my mom has are S768l and G719S. It’s very difficult finding concrete information regarding these mutations and treatment outcomes. Was...
Hi patneo and welcome to Grace. I'm so sorry your wife is going through this. It isn't possible or even legal to give advice to someone online unless it's in a...
Will doing an ct pet scan to look blood clot in lungs plus onc will be issuing an light dosage of Pemetrexed and carboplatin for a course and after that an...
Hi patneo,
I'm sorry but your wife's situation sounds too complicated to make judgments about possible best practices. I think our language barrier may be complicating our communication as well...because...